Ubiquitin–proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells

被引:0
|
作者
Ceshi Chen
Xiaodong Sun
Qimei Ran
Keith D Wilkinson
T J Murphy
Jonathan W Simons
Jin-Tang Dong
机构
[1] Winship Cancer Institute,Department of Oncology and Hematology
[2] Emory University School of Medicine,Department of Biochemistry
[3] Emory University School of Medicine,Department of Pharmacology
[4] Emory University School of Medicine,Department of Urology and Program in Genetics and Molecular Biology
[5] Emory University School of Medicine,undefined
来源
Oncogene | 2005年 / 24卷
关键词
KLF5; degradation; ubiquitin; proteasome; cancer;
D O I
暂无
中图分类号
学科分类号
摘要
Ubiquitin-mediated proteolysis plays a central role in controlling intracellular levels of essential regulatory molecules such as p53, cyclins, myc, BRCA1, HIF-1α, etc. The Kruppel-like factor 5 (KLF5) transcription factor regulates biological processes involved in carcinogenesis, angiogenesis, and smooth muscle cell differentiation. In carcinogenesis, KLF5's role has been indicated by frequent genetic deletion as well as functional studies. Here we show that KLF5 is an unstable protein with a short half-life. Destruction of KLF5 was prevented by each of the proteasome-specific inhibitors tested but not by an inhibitor for trypsin-like proteases and cysteine proteases or by a lysosome inhibitor in epithelial cells. Furthermore, KLF5 underwent ubiquitination, and deletion of a 56-amino-acid sequence adjacent to a known transactivation domain of KLF5 significantly reduced its ubiquitination and degradation. Interestingly, cancer cells appeared to be more active in KLF5 degradation than untransformed epithelial cells, yet their proteasome activity was not higher. These results suggest that KLF5 protein is degraded at least in part through ubiquitination–proteasome pathway, which may have become hyperactive for KLF5 in cancer cells.
引用
收藏
页码:3319 / 3327
页数:8
相关论文
共 50 条
  • [1] Ubiquitin-proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells
    Chen, CS
    Sun, XD
    Ran, QM
    Wilkinson, KD
    Murphy, TJ
    Simons, JW
    Dong, JT
    ONCOGENE, 2005, 24 (20) : 3319 - 3327
  • [2] Proteasomal degradation of the KLF5 transcription factor through a ubiquitin-independent pathway
    Chen, Ceshi
    Zhou, Zhongmei
    Guo, Peng
    Dong, Jin-Tang
    FEBS LETTERS, 2007, 581 (06) : 1124 - 1130
  • [3] The role of KLF5 transcription factor in breast cancer
    Chen, Ceshi
    CANCER SCIENCE, 2021, 112 : 225 - 225
  • [4] Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells
    Chen, CS
    Zhou, YF
    Zhou, ZM
    Sun, XD
    Otto, KB
    Uht, RM
    Dong, JT
    GENE, 2004, 330 : 133 - 142
  • [5] Curcumin Promotes KLF5 Proteasome Degradation through Downregulating YAP/TAZ in Bladder Cancer Cells
    Gao, Yang
    Shi, Qi
    Xu, Shan
    Du, Chong
    Liang, Liang
    Wu, Kaijie
    Wang, Ke
    Wang, Xinyang
    Chang, Luke S.
    He, Dalin
    Guo, Peng
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (09) : 15173 - 15187
  • [6] Significance of the transcription factor KLF5 in cardiovascular remodeling
    Nagai, R
    Suzuki, T
    Aizawa, K
    Shindo, T
    Manabe, I
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (08) : 1569 - 1576
  • [7] The roles and regulation of the KLF5 transcription factor in cancers
    Luo, Yao
    Chen, Ceshi
    CANCER SCIENCE, 2021, 112 (06) : 2097 - 2117
  • [8] Basic transcription factor KLF5 plays a role in TGF-β-mediated growth inhibition in epithelial cells
    Guo, Peng
    Dong, Xue-Yuan
    Chen, Ce-Shi
    Sun, Xiao-Dong
    Dong, Jin-Tang
    CANCER RESEARCH, 2006, 66 (08)
  • [9] Opposing Effects of KLF5 on the Transcription of MYC in Epithelial Proliferation in the Context of Transforming Growth Factor β
    Guo, Peng
    Dong, Xue-Yuan
    Zhao, Kewen
    Sun, Xiaodong
    Li, Qunna
    Dong, Jin-Tang
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (41) : 28243 - 28252
  • [10] A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer
    Chen, C
    Bhalala, HV
    Qiao, H
    Dong, JT
    ONCOGENE, 2002, 21 (43) : 6567 - 6572